Finland· FI-REL-REL32161
Ribavirin Teva
A ribavirin product containing ribavirin, registered in Finland by Teva B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ribavirin is registered in 10 of 19 countries.
Countries holding a registration under ATC J05AP01 (ribavirin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Ribavirin · ATC J05AP01
10 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Ribavirin
- Manufacturer
- Teva B.V.
- Country
- Finland (FI)
- ATC code
- J05AP01
- ATC class
- Ribavirin
- Defined daily dose
- 6 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
143 interactions on record for ribavirin.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ribavirin · interactions on record
143 records
- 4 severe
- 4 moderate
- 135 info
Most severe, free to view
- MercaptopurineL01BB02severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- AzathioprineL04AX01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ribavirin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainREBETOL 200 MG CAPSULAS DURASMerck Sharp & Dohme B.V.
- BelgiumRebetol 200 mgMerck Sharp & Dohme
- United KingdomRebetol 200mg capsulesMerck Sharp & Dohme (UK) Ltd
- SwedenRibavirin Mylan 200 mg Kapsel, hårdMylan S.A.S.
- PolandRebetolMerck Sharp & Dohme B.V.
- United StatesRibavirinAurobindo Pharma Limited
- FranceREBETOL 40 mg/ml, solution buvableMERCK SHARP & DOHME (PAYS-BAS)
- NorwayRibavirin aurobindoAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Cyprus · Ribavirin Aurobindo
- Germany · Ribavirin Ratiopharm
- Spain · Ribavirina Normon
- France · Ribavirine Pharmadev, Ribavirine Skyepharma
- United Kingdom (Northern Ireland) · Ribavirin Milpharm
- Italy · Ribavirina Aurobindo
- Netherlands · Ribavirine Ratiopharm
- Portugal · Ribavirina Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/49a6a8e6-652c-4850-86f4-8fecdd811a37 GET /v1/drugs/49a6a8e6-652c-4850-86f4-8fecdd811a37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "kapseli, kova",
"route": null,
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "ribaviriini",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/09/509/001-004",
"fimea_rel_id": "REL32161",
"authorised_at": "2009-03-31"
}See everything about ribavirin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.